British researchers learned that the risk of attention-deficit/hyperactivity disorder was at least four times higher in children of mothers who took blood pressure drugs labetalol or methyldopa while pregnant. Despite the finding, the Royal College of Obstetricians and Gynaecologists said the benefits of anti-hypertensive medicines still outweigh their risks based on existing studies.

Related Summaries